We are pleased to announce the acceptance of our abstract, “RNA-seq Analysis of Liver from Diabetic and NASH Model Mouse Treated with Streptozotocin, High-Fat Diet”, for presentation in the category “Integrated Physiology—Liver” at the 81st Annual Meeting of the American Diabetes Association, to be held from June 25 to 29, 2021.

The poster will also be published online on the journal Diabetes® website.

As a leading CRO in the field of inflammatory and fibrotic disease, we are continually accumulating data on our mouse models. This research was submitted to the ADA, which has a strict admission rate, and was accepted for poster presentation.

Attendees of the 81st Annual Meeting of the American Diabetes Association should make sure to take a look at our virtual presentation!